Fen-phen, heavily marketed in the 1990s, caused heart valve problems while rimonabant became linked with suicidal thinking and depression, leading an FDA advisory committee to recommend against approving it in 2007.
In September 2009, the therapist became concerned about Lynne's "suicidal thoughts, " although Lynne revealed no plan to kill herself, according to medical records.